Bioequivalence study of Metformin 500 mg tablet
Not Applicable
Recruiting
- Conditions
- In the present study, the products will be administered to healthy volunteers.
- Registration Number
- IRCT20210519051345N66
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
General Health (in terms of Liver, Heart and Kidney)
Age (18-59 years)
Exclusion Criteria
Smoking
History of cardiovascular disease, liver and kidney disease
Pregnancy
Alcohol and drug addiction
History of drug allergy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of Metformin in glucose regulation and insulin sensitivity?
How does the bioavailability of generic Metformin compare to the innovator product in fasted-state trials?
Which biomarkers are associated with Metformin response in type 2 diabetes patients?
What are the common adverse events of Metformin and how are they managed in clinical practice?
How does Metformin compare to other biguanides in terms of efficacy and safety profiles?